Basal ganglia activity in pathological gambling: A fluorodeoxyglucose- positron emission tomography study

Neuropsychobiology

Volumn 62, Issue 2, 2010, Pages 132-138

  Pallanti, Stefano ^a   Haznedar, M Mehmet ^a   Hollander, Eric ^a   Licalzi, Elizabeth M ^a   Bernardi, Silvia ^a   Newmark, Randall ^a   Buchsbaum, Monte S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Lithium; Pathological gambling; Relative glucose metabolic rate; Striatum; Thalamus

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LITHIUM; PLACEBO; LITHIUM CHLORIDE; TRANQUILIZER;

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; MALE; METABOLIC RATE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PATHOLOGICAL GAMBLING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RANDOMIZED CONTROLLED TRIAL; THALAMUS; BRAIN MAPPING; DIAGNOSTIC USE; DRUG EFFECTS; GAMBLING; HEMISPHERIC DOMINANCE; IMPULSE CONTROL DISORDERS; MIDDLE AGED; PATHOLOGY; PROCEDURES; PSYCHOLOGY; SCINTISCANNING;

ADULT; ANTIMANIC AGENTS; BASAL GANGLIA; BRAIN MAPPING; FEMALE; FLUORODEOXYGLUCOSE F18; FUNCTIONAL LATERALITY; GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS; LITHIUM CHLORIDE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 77953935341     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317286     Document Type: Article

References (41)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, text rev. Washington, American Psychiatric Association, 2000.
2. Potenza MN: The neurobiology of pathological gambling. Semin Clin Neuropsychiatry 2001; 6: 217-226.
3. Hollander E: Behavioral addictions and dirty drugs. CNS Spectr 2009; 14: 60-61.
4. Potenza MN, Steinberg MA, Skudlarski P, Fulbright RK, Lacadie CM, Wilber MK, et al. ambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry 2003; 60: 828-836.
5. Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, et al. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology 2008; 58: 37-47.
6. Potenza MN, Leung HC, Blumberg HP, Peterson BS, Fulbright RK, Lacadie CM, et al. An fMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry 2003; 160: 1990-1994.
7. Goldstein RZ, Volkow ND: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642-1652.
8. Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grüsser SM, et al. Correlation between dopamine D 2 receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 2004; 161: 1783-1789.
9. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW, et al. Functionalmagnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry 1998; 155: 124-126.
10. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, et al. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003; 23: 11461-11468.
11. Elliott R, Friston KJ, Dolan RJ: Dissociable neural responses in human reward systems. J Neurosci 2000; 20: 6159-6165.
12. Ramnani N, Miall RC: Instructed delay activity in the human prefrontal cortex is modulated by monetary reward expectation. Cereb Cortex 2003; 13: 318-327.
13. Knutson B, Cooper JC: Functional magnetic resonance imaging of reward prediction. Curr Opin Neurol 2005; 18: 411-417.
14. Yamada H, Matsumoto N, Kimura M: History-and current instruction-based coding of forthcoming behavioral outcomes in the striatum. J Neurophysiol 2007; 98: 3557-3567.
15. Melrose RJ, Poulin RM, Stern CE: An fMRI investigation of the role of the basal ganglia in reasoning. Brain Res 2007; 1142: 146-158.
16. Zink CF, Pagnoni G, Martin-Skurski ME, Chappelow JC, Berns GS: Human striatal responses to monetary reward depend on saliency. Neuron 2004; 42: 509-517.
17. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, et al. Amphetamineinduced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 2001; 49: 81-96.
18. Marazziti D, Catena DM, Conversano C, Consoli G, Vivarelli L, Mungai F, et al. Executive function abnormalities in pathological gamblers. Clin Pract Epidemol Ment Health 2008; 4: 7.
19. Hazlett EA, Buchsbaum MS, Mohs RC, Spiegel-Cohen J, Wei TC, Azueta R, et al. Agerelated shift in brain region activity during successful memory performance. Neurobiol Aging 1998; 19: 437-445.
20. Delis D, Kramer J, Kaplan E, Ober B: The California Verbal Learning Test. New York, Psychological Corporation, 1987.
21. Hazlett EA, Buchsbaum MS, Byne W, Wei TC, Spiegel-Cohen J, Genève C, et al. Threedimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry 1999; 156: 1190-1199.
22. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart, Thieme, 1988.
23. Woods RP, Mazziotta JC, Cherry SR: MRIPET registration with automated algorithm. J Comput Assist Tomogr 1993; 17: 536-546.
24. Brickman AM, Buchsbaum MS, Shihabuddin L, Hazlett EA, Borod JC, Mohs RC: Striatal size, glucose metabolic rate, and verbal learning in normal aging. Brain Res Cogn Brain Res 2003; 17: 106-116.
25. Buchsbaum MS, Shihabuddin L, Brickman AM, Miozzo R, Prikryl R, Shaw R, et al. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res 2003; 64: 53-62.
26. Haznedar MM, Buchsbaum MS, Hazlett EA, LiCalzi EM, Cartwright C, Hollander E: Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiatry 2006; 163: 1252-1263.
27. Kemether EM, Buchsbaum MS, Byne W, Hazlett EA, Haznedar M, Brickman AM, et al. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch Gen Psychiatry 2003; 60: 983-991.
28. Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S, et al. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 1999; 21: 683-693.
29. Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive- compulsive disorder. Arch Gen Psychiatry 1992; 49: 681-689.
30. Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, et al. [ 18 F]FDG PET study in obsessive-compulsive disorder: a clinical/ metabolic correlation study after treatment. Br J Psychiatry 1995; 166: 244-250.
31. Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM: Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 2004; 19: 755-760.
32. Monchi O, Petrides M, Strafella AP, Worsley KJ, Doyon J: Functional role of the basal ganglia in the planning and execution of actions. Ann Neurol 2006; 59: 257-264.
33. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-381.
34. Lawrence AD, Weeks RA, Brooks DJ, Andrews TC, Watkins LH, Harding AE, et al. The relationship between striatal dopamine receptor binding and cognitive performance in Huntingtons disease. Brain 1998; 121: 1343-1355.
35. Middleton FA, Strick PL: The temporal lobe is a target of output from the basal ganglia. Proc Natl Acad Sci USA 1996; 93: 8683-8687.
36. Haluk DM, Floresco SB: Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology 2009; 34: 2041-2052.
37. White NM, McDonald RJ: Multiple parallel memory systems in the brain of the rat. Neurobiol Learn Mem 2002; 77: 125-184.
38. Robbins TW, Everitt BJ: Drug addiction: bad habits add up. Nature 1999; 398: 567-570.
39. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F: Imaging dopamines role in drug abuse and addiction. Neuropharmacology 2009; 56(suppl 1):3-8.
40. Grace AA, Floresco SB, Goto Y, Lodge DJ: Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 2007; 30: 220-227.
41. Sesack SR, Carr DB: Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol Behav 2002; 77: 513-517.